Assignee
DNA TWOPOINTO INC
US·26 granted patents·10 pending applications·291 citations·filing 2004–2025
Top patents by PatentIndex Score
36 records- 0198US11060098B2Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryziasDNA TWOPOINTO INC·Filed 2020·Granted Jul 13, 2021·10 cites·23 claims
- 0298US11060109B2Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyeloisDNA TWOPOINTO INC·Filed 2020·Granted Jul 13, 2021·9 cites·23 claims
- 0397US11162102B2Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their productsDNA TWOPOINTO INC·Filed 2020·Granted Nov 2, 2021·99 cites·24 claims
- 0497US11060086B2Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothisDNA TWOPOINTO INC·Filed 2020·Granted Jul 13, 2021·9 cites·23 claims
- 0596US7561972B1Synthetic nucleic acids for expression of encoded proteinsDNA TWOPOINTO INC·Filed 2008·Granted Jul 14, 2009·45 cites·20 claims
- 0696US7561973B1Methods for determining properties that affect an expression property value of polynucleotides in an expression systemDNA TWOPOINTO INC·Filed 2008·Granted Jul 14, 2009·53 cites·20 claims
- 0792US8005620B2Systems and methods for biopolymer engineeringDNA TWOPOINTO INC·Filed 2004·Granted Aug 23, 2011·27 cites·44 claims
- 0891US10927384B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2016·Granted Feb 23, 2021·4 cites·20 claims
- 0991US9290552B2Fluorescent and colored proteins and methods for using themDNA TWOPOINTO INC·Filed 2014·Granted Mar 22, 2016·8 cites·21 claims
- 1090US11566262B2Tetracycline-inducible expression systemsDNA TWOPOINTO INC·Filed 2022·Granted Jan 31, 2023·1 cites·33 claims
- 1190US11401521B2Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryziasDNA TWOPOINTO INC·Filed 2021·Granted Aug 2, 2022·1 cites·30 claims
- 1290US2025043235A1Dna vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2024·Application pending·0 cites
- 1388US9206433B2Methods, compositions and kits for a one-step DNA cloning systemDNA TWOPOINTO INC·Filed 2013·Granted Dec 8, 2015·7 cites·16 claims
- 1488US8975042B2Fluorescent and colored proteins and methods for using themDNA TWOPOINTO INC·Filed 2013·Granted Mar 10, 2015·6 cites·24 claims
- 1587US9493521B2Fluorescent and colored proteins and methods for using themDNA TWOPOINTO INC·Filed 2016·Granted Nov 15, 2016·3 cites·20 claims
- 1686US11713468B2DNA vectors and elements for sustained gene expression in eukaryotic cellsDNA TWOPOINTO INC·Filed 2018·Granted Aug 1, 2023·2 cites·18 claims
- 1785US2024093196A1Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their productsDNA TWOPOINTO INC·Filed 2023·Application pending·0 cites
- 1882US12351800B2Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their productsDNA TWOPOINTO INC·Filed 2022·Granted Jul 8, 2025·0 cites·18 claims
- 1981US7805252B2Systems and methods for designing and ordering polynucleotidesDNA TWOPOINTO INC·Filed 2005·Granted Sep 28, 2010·4 cites·69 claims
- 2080US9102944B2Methods, compositions and kits for one-step DNA cloning using DNA topoisomeraseDNA TWOPOINTO INC·Filed 2012·Granted Aug 11, 2015·2 cites·28 claims
- 2180US2022282260A1Dna vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2022·Application pending·0 cites
- 2279US12590319B2Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyeloisDNA TWOPOINTO INC·Filed 2022·Granted Mar 31, 2026·0 cites·15 claims
- 2379US12351813B2Tetracycline-inducible expression systemDNA TWOPOINTO INC·Filed 2022·Granted Jul 8, 2025·0 cites·29 claims
- 2478US11845936B2Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their productsDNA TWOPOINTO INC·Filed 2021·Granted Dec 19, 2023·0 cites·29 claims
- 2578US11396662B2Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyeloisDNA TWOPOINTO INC·Filed 2021·Granted Jul 26, 2022·0 cites·30 claims
- 2678US9771402B2Fluorescent and colored proteins and methods for using themDNA TWOPOINTO INC·Filed 2016·Granted Sep 26, 2017·1 cites·20 claims
- 2776US12054702B2DNA vectors, transposons and transposases for eukaryotic genome modificationDNA TWOPOINTO INC·Filed 2021·Granted Aug 6, 2024·0 cites·7 claims
- 2875US2023103199A1Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryziasDNA TWOPOINTO INC·Filed 2022·Application pending·0 cites
- 2975US2024052367A1Dna vectors and elements for sustained gene expression in eukaryotic cellsDNA TWOPOINTO INC·Filed 2023·Application pending·0 cites
- 3071US12404504B2Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothisDNA TWOPOINTO INC·Filed 2021·Granted Sep 2, 2025·0 cites·17 claims
- 3166US2026098094A1Cµ4 REGION FOR PAIRING HEAVY AND LIGHT CHAINS IN MULTI-SPECIFIC ANTIBODIESDNA TWOPOINTO INC·Filed 2025·Application pending·0 cites
- 3264US2025207109A1Engineered split dhfr-based methods and systems for selecting cells that have stably acquired a heterologous polynucleotideDNA TWOPOINTO INC·Filed 2023·Application pending·0 cites
- 3362US12419913B2Modification of CAR-T cellsDNA TWOPOINTO INC·Filed 2023·Granted Sep 23, 2025·0 cites·20 claims
- 3459US2014032186A1Systems and methods for antibody engineeringDNA TWOPOINTO INC·Filed 2013·Application pending·0 cites
- 3559US2023313187A1Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their productsDNA TWOPOINTO INC·Filed 2021·Application pending·0 cites
- 3645US2022170044A1Transposon-based modifications of immune cellsDNA TWOPOINTO INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DNA TWOPOINTO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →